In vivo immune modulatory activity of hepatic stellate cells in mice

被引:130
作者
Chen, Cheng-Hsu
Kuo, Liang-Mou
Chang, Yigang
Wu, Wenhan
Goldbach, Christina
Ross, Mark A.
Stolz, Donna B.
Chen, Liepin
Fung, John J.
Lu, Lin
Qian, Shiguang
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA
[2] Thomas E Starzl Transplantat Inst, Dept Surg, Pittsburgh, PA USA
[3] Childrens Hosp Pittsburgh, Div Immunogenet, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA
[5] Cleveland Clin Fdn, Dept Gen Surg, Cleveland, OH 44195 USA
[6] Johns Hopkins Univ, Sch Med, Dept Dermatol & Oncol, Baltimore, MD USA
关键词
D O I
10.1002/hep.21379
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accumulating data suggest that hepatic tolerance, initially demonstrated by spontaneous acceptance of liver allografts in many species, results from an immune regulatory activity occurring in the liver. However, the responsible cellular and molecular components have not been completely understood. We have recently described profound T cell inhibitory activity of hepatic stellate cells (HSCs) in vitro. In this study, we demonstrate in vivo evidence of immune modulatory activity of HSCs in mice using an islet transplantation model. Co-transplanted HSCs effectively protected islet allografts from rejection, forming a multilayered capsule, which reduced allograft immunocyte infiltrates by enhancement of apoptotic death. The immune modulation by HSCs appeared to be a local effect, and regulated by inducible expression of B7-H1, an inhibitory molecule of B7 family. This may reflect an intrinsic mechanism of immune inhibition mediated by liver-derived tissue cells. In conclusion, these results may lead to better understanding of liver immunobiology and development of new strategies for treatment of liver diseases.
引用
收藏
页码:1171 / 1181
页数:11
相关论文
共 43 条
  • [1] Indoleamine 2,3-dioxygenase expression in trans-planted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes
    Alexander, AM
    Crawford, M
    Bertera, S
    Rudert, WA
    Takikawa, O
    Robbins, PD
    Trucco, M
    [J]. DIABETES, 2002, 51 (02) : 356 - 365
  • [2] Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO
  • [3] 2-K
  • [4] Hepatic stellate cells as a target for the treatment of liver fibrosis
    Bataller, R
    Brenner, DA
    [J]. SEMINARS IN LIVER DISEASE, 2001, 21 (03) : 437 - 451
  • [5] A functional model of hepatocyte transplantation for in vivo immunologic studies
    Bumgardner, GL
    Heininger, M
    Li, JS
    Xia, DY
    Parker-Thornburg, J
    Ferguson, RM
    Orosz, CG
    [J]. TRANSPLANTATION, 1998, 65 (01) : 53 - 61
  • [6] Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells
    Bumgardner, GL
    Orosz, CG
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 174 : 260 - 279
  • [7] INDUCTION OF IMMUNOLOGICAL TOLERANCE BY PORCINE LIVER ALLOGRAFTS
    CALNE, RY
    SELLS, RA
    PENA, JR
    DAVIS, DR
    MILLARD, PR
    HERBERTSON, BM
    BINNS, RM
    DAVIES, DAL
    [J]. NATURE, 1969, 223 (5205) : 472 - +
  • [8] Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO
  • [9] 2-9
  • [10] B7-H1 connection of innate and adaptive immunity against tumor dormancy
    Chen, LP
    [J]. BLOOD, 2005, 105 (06) : 2242 - 2243